These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39532011)

  • 1. Novel 5-Fluorouracil analogues versus perfluorophenyl ureas as potent anti-breast cancer agents: Design, robust synthesis, in vitro, molecular docking, pharmacokinetics ADMET analysis and dynamic simulations.
    Sroor FM; El-Sayed AF; Mahmoud K
    Bioorg Chem; 2024 Dec; 153():107944. PubMed ID: 39532011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel diaryl urea-oxindole hybrids as BRAF kinase inhibitors targeting BRAF and KRAS mutant cancers.
    Ghannam IAY; El Kerdawy AM; Mounier MM; Abo-Elfadl MT; Abdel-Mohsen HT
    Bioorg Chem; 2024 Dec; 153():107848. PubMed ID: 39368145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico inspired design of urea noscapine congeners as anticancer agents: Chemical synthesis and experimental evaluation using breast cancer cells and a xenograft mouse model.
    Pragyandipta P; Naik E; Reddy PK; Nayek A; Kantevari S; Naik PK
    Eur J Med Chem; 2025 Jan; 282():117091. PubMed ID: 39602993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of S-alkylated oxadiazole bearing imidazo[2,1-b]thiazole derivatives targeting breast cancer: In vitro cytotoxic evaluation and in vivo radioactive tracing studies.
    Mohammed ER; Abdel Fattah Ezzat M; Seif EM; Essa BM; Abdel-Aziz HA; Sakr TM; Ibrahim HS
    Bioorg Chem; 2024 Dec; 153():107935. PubMed ID: 39504637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, molecular docking, pharmacokinetics, and molecular dynamics of new bis-thiazoles based on bis-thiosemicarbazone as anti-coxsackievirus.
    Farghaly TA; Abbas EMH; Abd-Elghaffar HS; Elsayed MA; Elnaggar DH; El-Sayed AF; Abd-Elshafy DN; Mohamed SF
    Sci Rep; 2024 Nov; 14(1):29378. PubMed ID: 39592765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing new anticancer agents: Design, synthesis, biological evaluation and in silico study of several functionalized pyrimidine-5-carbonitriles as small molecules modulators targeting breast cancer.
    Badawi WA; Okda TM; Abd El Wahab SM; Ezz-ElDien ES; AboulWafa OM
    Bioorg Chem; 2024 Dec; 153():107953. PubMed ID: 39556931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the anticancer mechanism of 1,2,3-triazole-incorporated thiazole-pyrimidine-isoxazoles: insights from docking and molecular dynamics simulations.
    Sireesha R; Pavani Y; Mallavarapu BD; Abbasi BA; Guttula PK; Subbarao M
    J Biomol Struct Dyn; 2024; 42(24):13803-13815. PubMed ID: 38038384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells.
    Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V
    J Biomol Struct Dyn; 2024; 42(23):13114-13129. PubMed ID: 37948299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studies.
    Elkady H; Elgammal WE; Mahdy HA; Zara S; Carradori S; Husein DZ; Alsfouk AA; Ibrahim IM; Elkaeed EB; Metwaly AM; Eissa IH
    Comput Biol Chem; 2024 Dec; 113():108221. PubMed ID: 39332241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and
    Gujja V; Sadineni K; Koppula SK; Basireddy A; Venkanna B; Gunda SK
    Curr Drug Discov Technol; 2025; 22(1):e090424228867. PubMed ID: 38616757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation.
    Shah A; Teraiya N; Kamdar JH; Juneja T; Sangani CB; Ahmed S; Kapadiya K
    Bioorg Chem; 2024 Dec; 153():107841. PubMed ID: 39326340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in-vitro, in-silico, DFT and POM studies of a novel family of sulfonamides as potent anti-triple-negative breast cancer agents.
    Saghdani N; El Abbouchi A; El Brahmi N; Idir A; Rachedi KO; Berredjem M; Haloui R; Elkhattabi S; Mouse HA; Ben Hadda T; Bousmina M; Zyad A; El Kazzouli S
    Comput Biol Chem; 2024 Dec; 113():108214. PubMed ID: 39305691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening, molecular dynamics simulations, and in vitro validation of EGFR inhibitors as breast cancer therapeutics.
    Shetty SR; Debnath S; Majumdar K; Rajagopalan M; Ramaswamy A; Das A
    Bioorg Chem; 2024 Dec; 153():107849. PubMed ID: 39368144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical Metal-Free synthesis and biological Assessment of isocryptolepine analogues targeting estrogen receptor Alpha in breast cancer cells.
    Bogdanov FB; Balakhonov RY; Volkov ES; Sonin IV; Andreeva OE; Sorokin DV; Piven YA; Scherbakov AM; Shirinian VZ
    Bioorg Chem; 2024 Dec; 153():107942. PubMed ID: 39515131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies.
    Fadaly WAA; Mohamed FEA; Nemr MTM; Sayed AM; Khalil RG; Zidan TH
    Bioorg Chem; 2024 Dec; 153():107881. PubMed ID: 39396453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hydrazide-hydrazone containing 1,2,4-triazole as potent inhibitors of antiapoptotic protein Bcl-xL: Synthesis, biological evaluation, and docking studies.
    Kuran ED; Uner B; Cam ME; Ulusoy-Guzeldemirci N
    Arch Pharm (Weinheim); 2024 Dec; 357(12):e2400562. PubMed ID: 39344558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strategy to bind pyrimidine sulfonamide derivatives with odd even chains: exploration of their design, synthesis and biological activity evaluation.
    Zhou M; Liu Y; Wang S; Feng J; Ni H; Lu C; Jin G
    Mol Divers; 2024 Oct; 28(5):3011-3026. PubMed ID: 38082105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology and experimental validation for deciphering the action mechanism of
    Bhat BA; Rashid Mir W; Alkhanani M; Almilaibary A; Mir MA
    J Biomol Struct Dyn; 2024; 42(23):13002-13022. PubMed ID: 37948293
    [No Abstract]   [Full Text] [Related]  

  • 20. Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies.
    Irfandi R; Raya I; Ahmad A; Fudholi A; Riswandi ; Santi S; Azalea WP; Putri SE; Alam MN; Supratman U; Olubode SO; Abdalrazaq EA; Kandeel M; Soekamto NH; Natsir H; Maming ; Ramlawati
    Mol Divers; 2024 Oct; 28(5):3199-3214. PubMed ID: 37884781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.